The Institute of Biomedicine of Seville (IBiS), in Spanish Instituto de Biomedicina de Sevilla (IBiS), has been awarded the “Accreditation Centros Fundación” by the Scientific Foundation of the Spanish Association Against Cancer (AECC), in Spanish Fundación Científica de la Asociación Española Contra el Cáncer (AECC). This prestigious recognition highlights the scientific excellence and institutional management quality of the center, both fundamental aspects in cancer research.

IBiS is one of the 13 centers in Spain to receive this accreditation, which will allow it to strengthen coordination and international research networks on cancer. Additionally, this recognition will help support research talent through a career plan and recruitment strategies for highly qualified personnel. Furthermore, this distinction will increase IBiS’s visibility and global impact, enhancing its competitiveness in funding calls and technology transfer to the productive sector.

With this distinction granted by the AECC, IBiS reinforces its commitment to translational research, which aims to bring scientific discoveries into clinical practice to directly improve cancer treatment and prevention. Thanks to this recognition, the center will have new opportunities to collaborate with other research centers and hospitals at both the national and international levels, fostering the creation of synergies that drive progress in this field.

Moreover, it serves as a boost to strengthen coordination and international networks in cancer research, support research talent in oncology through a career plan and recruitment strategies for highly qualified personnel, and increase IBiS’s global visibility and impact, enhancing its competitiveness in funding calls and technology transfer to the productive sector.

This recognition consolidates IBiS as a national and international benchmark in the fight against cancer, aligning with the global goal of achieving a 70% survival rate for this disease by the year 2030.